New York, NY, United States of America

Marian Orlowski


Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 1978-2009

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Marian Orlowski

Introduction

Marian Orlowski is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of immunology and proteolysis, holding a total of 3 patents. Her work focuses on developing novel therapeutic methods for treating various diseases, including cancer and autoimmune disorders.

Latest Patents

One of her latest patents is titled "Potent and specific immunoproteasome inhibitors." This invention describes compounds and methods for selectively inhibiting an immunoproteasome. It also outlines methods for treating cancer, inflammation, and autoimmune diseases by administering a therapeutic amount of an immunoproteasome-specific inhibitor to a subject in need. Another notable patent is "Substrate-related peptidyl-aldehyde inhibitors of the proteolytic." This invention provides novel peptidylaldehyde inhibitors that target proteolysis mediated by the multicatalytic proteinase complex (MPC) or proteasome.

Career Highlights

Throughout her career, Marian has worked with esteemed institutions such as Mount Sinai School of Medicine and the University of North Carolina at Chapel Hill. Her research has significantly advanced the understanding of immunoproteasomes and their role in disease treatment.

Collaborations

Marian has collaborated with notable colleagues, including Robert Z Orlowski and Christopher Cardozo. These partnerships have further enriched her research and contributed to her innovative work in the field.

Conclusion

Marian Orlowski's contributions to immunology and proteolysis exemplify her dedication to advancing medical science. Her innovative patents and collaborations highlight her role as a leading inventor in her field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…